Prevalent diabetes and risk of total, colorectal, prostate and breast cancers in an ageing population: meta-analysis of individual participant data from cohorts of the CHANCES consortium
- PMID: 33772152
- PMCID: PMC8144608
- DOI: 10.1038/s41416-021-01347-4
Prevalent diabetes and risk of total, colorectal, prostate and breast cancers in an ageing population: meta-analysis of individual participant data from cohorts of the CHANCES consortium
Abstract
Background: We investigated whether associations between prevalent diabetes and cancer risk are pertinent to older adults and whether associations differ across subgroups of age, body weight status or levels of physical activity.
Methods: We harmonised data from seven prospective cohort studies of older individuals in Europe and the United States participating in the CHANCES consortium. Cox proportional hazard regression was used to estimate the associations of prevalent diabetes with cancer risk (all cancers combined, and for colorectum, prostate and breast). We calculated summary risk estimates across cohorts using pooled analysis and random-effects meta-analysis.
Results: A total of 667,916 individuals were included with an overall median (P25-P75) age at recruitment of 62.3 (57-67) years. During a median follow-up time of 10.5 years, 114,404 total cancer cases were ascertained. Diabetes was not associated with the risk of all cancers combined (hazard ratio (HR) = 0.94; 95% confidence interval (CI): 0.86-1.04; I2 = 63.3%). Diabetes was positively associated with colorectal cancer risk in men (HR = 1.17; 95% CI: 1.08-1.26; I2 = 0%) and a similar HR in women (1.13; 95% CI: 0.82-1.56; I2 = 46%), but with a confidence interval including the null. Diabetes was inversely associated with prostate cancer risk (HR = 0.81; 95% CI: 0.77-0.85; I2 = 0%), but not with postmenopausal breast cancer (HR = 0.96; 95% CI: 0.89-1.03; I2 = 0%). In exploratory subgroup analyses, diabetes was inversely associated with prostate cancer risk only in men with overweight or obesity.
Conclusions: Prevalent diabetes was positively associated with colorectal cancer risk and inversely associated with prostate cancer risk in older Europeans and Americans.
Conflict of interest statement
The authors declare no competing interests.
Figures



Similar articles
-
Comparison of general obesity and measures of body fat distribution in older adults in relation to cancer risk: meta-analysis of individual participant data of seven prospective cohorts in Europe.Br J Cancer. 2017 May 23;116(11):1486-1497. doi: 10.1038/bjc.2017.106. Epub 2017 Apr 25. Br J Cancer. 2017. PMID: 28441380 Free PMC article.
-
Pre- and Post-diagnosis Diabetes as a Risk Factor for All-Cause and Cancer-Specific Mortality in Breast, Prostate, and Colorectal Cancer Survivors: a Prospective Cohort Study.Front Endocrinol (Lausanne). 2020 Feb 18;11:60. doi: 10.3389/fendo.2020.00060. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32132977 Free PMC article.
-
Work stress and risk of cancer: meta-analysis of 5700 incident cancer events in 116,000 European men and women.BMJ. 2013 Feb 7;346:f165. doi: 10.1136/bmj.f165. BMJ. 2013. PMID: 23393080 Free PMC article.
-
Adherence to the WCRF/AICR Dietary Recommendations for Cancer Prevention and Risk of Cancer in Elderly from Europe and the United States: A Meta-Analysis within the CHANCES Project.Cancer Epidemiol Biomarkers Prev. 2017 Jan;26(1):136-144. doi: 10.1158/1055-9965.EPI-16-0428. Epub 2016 Oct 28. Cancer Epidemiol Biomarkers Prev. 2017. PMID: 27793797 Free PMC article. Review.
-
Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma.Int J Cancer. 2011 Mar 15;128(6):1414-24. doi: 10.1002/ijc.25439. Int J Cancer. 2011. PMID: 20473927
Cited by
-
The Effects of Mesenchymal Stem Cell on Colorectal Cancer.Stem Cells Int. 2021 Jul 24;2021:9136583. doi: 10.1155/2021/9136583. eCollection 2021. Stem Cells Int. 2021. PMID: 34349805 Free PMC article. Review.
-
2022 Update on Prostate Cancer Epidemiology and Risk Factors-A Systematic Review.Eur Urol. 2023 Aug;84(2):191-206. doi: 10.1016/j.eururo.2023.04.021. Epub 2023 May 16. Eur Urol. 2023. PMID: 37202314 Free PMC article.
-
The effect of SGLT2 inhibition on prostate cancer: Mendelian randomization and observational analysis using electronic healthcare and cohort data.Cell Rep Med. 2024 Aug 20;5(8):101688. doi: 10.1016/j.xcrm.2024.101688. Cell Rep Med. 2024. PMID: 39168098 Free PMC article.
-
Risk factors for prostate cancer: An umbrella review of prospective observational studies and mendelian randomization analyses.PLoS Med. 2024 Mar 15;21(3):e1004362. doi: 10.1371/journal.pmed.1004362. eCollection 2024 Mar. PLoS Med. 2024. PMID: 38489391 Free PMC article.
-
Prevalence of diabetes mellitus among 80,193 gastrointestinal cancer patients in five European and three Asian countries.J Cancer Res Clin Oncol. 2022 May;148(5):1057-1062. doi: 10.1007/s00432-021-03861-7. Epub 2021 Dec 12. J Cancer Res Clin Oncol. 2022. PMID: 34897573 Free PMC article.
References
-
- Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet. 2017;389:2239–2251. - PubMed
-
- Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat. Rev. Endocrinol. 2018;14:88–98. - PubMed
-
- Gouveri E, Papanas N, Maltezos E. The female breast and diabetes. Breast. 2011;20:205–211. - PubMed
-
- Tsilidis KK, Kasimis JC, Lopez DS, Ntzani EE, Ioannidis JPA. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ. 2015;350:g7607. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials